Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3Sanofi
02 7Orion Corporation
03 4Dr. Reddy's Laboratories
04 51A Pharma Gmbh
05 32care4
06 23M Health Care
07 2AMW GmbH
08 1Ababor Pharmaceuticals Sl
09 2Abacus Medicine
10 2Acino Pharma
11 4Actavis Inc
12 4Alembic Pharmaceuticals Limited
13 8Almirall
14 8Apotex Inc
15 4Arrow Aps
16 8Aurobindo Pharma Limited
17 4Chartwell Pharmaceuticals llc
18 1Cinfa
19 5Combix Laboratories Slu
20 5ELPEN Pharmaceutical
21 5Ebb Medical
22 5Farmalider SA
23 4GENERIC MEDICAL PARTNERS INC
24 1Galenicum
25 5Hexal AG
26 8JAMP PHARMA
27 9Karo Pharma
28 5Kern Pharma S.L.
29 8Knight Therapeutics
30 17Krka
31 4LABORATORIOS NORMON SA
32 2Luye Pharma
33 8Macleods Pharmaceuticals Limited
34 1Medartuum
35 3Mepha Pharma
36 14Novartis Pharmaceuticals Australia Pty Limited
37 21Novartis Pharmaceuticals Corporation
38 4Novartis South Africa (Pty) Ltd
39 7ORIFARM GROUP AS
40 4OrBion Pharmaceuticals
41 4Pharmascience Inc.
42 4Ratiopharm GmbH
43 13STADA Arzneimittel
44 27Sandoz B2B
45 5Sun Pharmaceutical Industries Limited
46 5Synthon Pharmaceuticals
47 7Teva Pharmaceutical Industries
48 1Torrefarma
49 5Unichem Laboratories Limited
50 1Vegal Farmaceutica Sl
51 8Viatris
52 2Vir Sa Chemical And Pharmaceutical Industry
53 5World Medicine
54 4Zydus Lifesciences
01 8CAP
02 32CAPSULE
03 44CAPSULE;ORAL
04 80Capsule
05 42Hard Capsule
06 1ORAL SOLUTION
07 19Oral Solution
08 4Orodispersible Tablet
09 7PATCH
10 1SOLUTION
11 1SOLUTION; ORAL
12 1SOLUTION;ORAL
13 54Transdermal Patch
14 14Blank
01 19Allowed
02 67Approved
03 38Authorized
04 11Cancelled
05 13DISCN
06 55Deregistered
07 14Generic
08 4Originator
09 36Prescription
10 32RX
11 4Suspensed
12 15Blank
01 4APO-RIVASTIGMINE
02 2Aldemyl
03 10EXELON
04 1EXELON PATCH 10
05 1EXELON PATCH 15
06 1EXELON PATCH 5
07 3Emerpand
08 23Exelon
09 1Exelon 1.5 mg
10 1Exelon 6 mg
11 3Exelon Patch
12 2Exelon Patch 10
13 2Exelon Patch 15
14 2Exelon Patch 5
15 4JAMP RIVASTIGMINE
16 4JAMP RIVASTIGMINE CAPSULES
17 1Kyriz 1,5 MG
18 1Kyriz 3 MG
19 1Kyriz 4,5 MG
20 1Kyriz 6 MG
21 4MED-RIVASTIGMINE
22 1MYLAN-RIVASTIGMINE PATCH 10
23 1MYLAN-RIVASTIGMINE PATCH 5
24 17Nimvastid
25 3Orivast
26 4PMS-RIVASTIGMINE
27 8Prometax
28 1RIVASTIGMINE
29 40RIVASTIGMINE TARTRATE
30 3Rigmin
31 2Rivastigmin Abacus Medicine
32 4Rivastigmin Mylan
33 4Rivastigmin Ratiopharm
34 4Rivastigmin Stada
35 4Rivastigmina Aurobindo
36 1Rivastigmina Cinfa
37 5Rivastigmina Combix
38 5Rivastigmina Farmalider
39 1Rivastigmina Galenicum Derma
40 5Rivastigmina Kern Pharma
41 1Rivastigmina Montvel
42 1Rivastigmina Ortodrol
43 10Rivastigmina Sandoz
44 4Rivastigmina Stadafarma
45 1Rivastigmina Torrefarma
46 1Rivastigmina Vir
47 5Rivastigmine 1 A Pharma
48 2Rivastigmine 3M Health Care Ltd.
49 1Rivastigmine Ababor
50 2Rivastigmine Acino
51 6Rivastigmine Actavis
52 2Rivastigmine Amw
53 4Rivastigmine Arrow
54 1Rivastigmine Ebb
55 5Rivastigmine Hexal
56 1Rivastigmine Medartuum
57 4Rivastigmine Normon
58 4Rivastigmine Orifarm
59 11Rivastigmine Orion
60 3Rivastigmine Patch Sandoz
61 5Rivastigmine Sandoz
62 2Rivastigmine Stada
63 3Rivastigmine Stada Medicines
64 5Rivastigmine Synthon
65 7Rivastigmine Teva
66 3Rivastigmine Zentiva Patch h
67 3Rivastigmine-Mepha Patch h
68 3Rivastor
69 2Rivasur twice weekly hours
70 4SANDOZ RIVASTIGMINE
71 1SANDOZ RIVASTIGMINE PATCH 10
72 1SANDOZ RIVASTIGMINE PATCH 5
73 5Telomena
74 10Blank
01 14Australia
02 36Canada
03 5India
04 8South Africa
05 53Spain
06 122Sweden
07 19Switzerland
08 5Turkey
09 46USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 4.6mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 13.3mg/24hours
Packaging :
Approval Date : 15/01/2020
Application Number : 20181221000018
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE TARTRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1.5MG BASE
Packaging :
Approval Date : 2007-10-31
Application Number : 77130
Regulatory Info : RX
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 9.5mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 13.3mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 4.6mg/24hours
Packaging :
Approval Date : 13/06/2013
Application Number : 20110507000046
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 9.5mg/24hours
Packaging :
Approval Date : 13/06/2013
Application Number : 20110507000053
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength : 1.5mg
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000025
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000049
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength : 4.5mg
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000056
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000063
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE TARTRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 3MG BASE
Packaging :
Approval Date : 2007-10-31
Application Number : 77130
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE TARTRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 4.5MG BASE
Packaging :
Approval Date : 2007-10-31
Application Number : 77130
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE TARTRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 6MG BASE
Packaging :
Approval Date : 2007-10-31
Application Number : 77130
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Authorized
Registration Country : Spain
Rivastigmine Hydrogen Tartrate
Brand Name : Nimvastid
Dosage Form : Hard Capsule
Dosage Strength : 6MG
Packaging :
Approval Date : 2015-09-24
Application Number : 109525024
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EXELON
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2000-04-21
Application Number : 20823
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EXELON
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2000-04-21
Application Number : 20823
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EXELON
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 4.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2000-04-21
Application Number : 20823
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Authorized
Registration Country : Spain
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmina Sandoz
Dosage Form : Hard Capsule
Dosage Strength : 6MG
Packaging :
Approval Date : 2012-06-21
Application Number : 09599014
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmina Stadafarma
Dosage Form : Hard Capsule
Dosage Strength : 1.5MG
Packaging :
Approval Date : 2012-10-08
Application Number : 76596
Regulatory Info : Authorized
Registration Country : Spain
